Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

The World Bank revised down Romania's 2026 growth forecast to 1.3%, compared to the 1.9% predicted in June 2025 and 2.6% estimated in January 2025.
Banks in Central Eastern South-Eastern Europe report improving trends, with credit demand remaining robust, particularly from companies, while banks anticipate improvement in credit supply following a period of contraction.
Agroland Business System has completed the acquisition of Avirom, a Romanian company specialising in day-old chick and duckling production.
Romania's inflation remained at 9.7% at the end of 2025, with mixed pressures across different spending categories in December.
Romania's annual inflation rate decreased to 9.69% in December from 9.76% in November, according to data published by the National Institute of Statistics (INS).